ALK and neoplasm: This was further supported by experiments in TPM3-ALK (conditional onco-ALK) MEF cells which showed that both ALK and HIF1α expression are a prerequisite for miR-16 downregulation; in agreement with these findings, increased miR-16 expression in vivo reduced angiogenesis and tumour growth [118].